Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Med Care. 2022 Mar 30;60(6):423–431. doi: 10.1097/MLR.0000000000001713

Table 4:

Incremental Cost Effectiveness

Base Case, cost per quality adjusted life year (QALY) using intervention replication cost, total medical care cost
Cost Incremental cost QALY Incremental QALY ICER
Control group $25,506 0.5459
Treatment group $23,665 −1841 0.5695 0.0236 Intervention Dominant
Cost-effectiveness plane quadrant results: SE 80%; NW 0%; NE 20%; SW 0%

Dominant means the intervention had lower costs and greater effect

Supplemental analysis difference from base-case shown in italics

Cost-effectiveness plane quadrant results legend:

SE=intervention was less costly and more effective; always cost-effective

NW=intervention was more costly and less effective; never cost-effective

NE=intervention was more costly and more effective; cost-effective depending on willingness-to-pay for a unit of effectiveness

SW=intervention was less costly and less effective; cost-effective depending on willingness-to-pay for a unit of effectiveness

All analyses adjusted for baseline cost and baseline outcome measure